AZD7789
Drug timelines are a Plus or Pro feature.
2 regulatory and trial events tracked for AZD7789, covering 2025-05-02 to 2025-10-09. Get the full timeline:
Most recent: Clinical Trial Update: A Study to Assess the Safety and Efficacy of AZD7789 in Participants With Advanced or Metastatic Solid Cancer [Phase 1, Phase 2]